+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Amniotic Products Market Size, Share & Industry Trends Analysis Report By Type (Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes), By Application, By End User, By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 216 Pages
  • July 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5869063
The Global Amniotic Products Market size is expected to reach $1.6 billion by 2030, rising at a market growth of 7.4% CAGR during the forecast period.

Diabetes slows wound healing, hence amniotic membranes and other sophisticated wound care products are required for treatment. Therefore, wound care segment would generate more than 40% share of the market by 2030. For example, diabetes and obesity can lead to a rise in ulcerations, such as leg or foot ulcers, requiring wound care and resulting in astronomical medical costs. According to the IDF 2021, 1 in 10 adults (aged 20 to 79) have diabetes. By 2030 and 2045, this number is projected to increase to 643 million and 783 million, respectively. Diabetes's severe consequences include diabetic foot ulcers. Consequently, the growing prevalence of diabetes will increase demand for wound care products. Some of the factors impacting the market are increasing number of burn injuries, growing interest and investment, and amniotic membrane products have a high price.



The WHO reports that most burn cases happen in low- and middle-income countries, with roughly two-thirds occurring in the WHO regions of Africa and Southeast Asia. The demand for these tissue-based solutions has also increased due to the rise in transplants that have occurred in recent years due to increased awareness. Additionally, several donations have seen a rise in awareness, fueling the market's revenue expansion. The rise in the geriatric population worldwide and the consequent rise in ophthalmology surgery have created a sizable demand for these tissue-based products. During the projection period, it is anticipated that actions such as increasing investments, a rise in partnerships and collaborations, and innovative product development strategies would support market expansion. As a result of the increasing interest and investment, the market will grow automatically.

However, Amniotic products must be processed and manufactured using specialized techniques to preserve their biological qualities and ensure their safety. The production cost may rise due to the considerable quality control, testing, and regulatory compliance involved in these procedures. As the prices of amniotic membrane products is high and the reimbursement scenario is poor, the market is estimated to witness slow growth.

COVID 19 Impact Analysis

The amniotic product market suffered in 2020 due to the COVID-19 outbreak's widespread lockdowns, refusal of wound care services, and cancellation or postponement of elective procedures. Elective operations were rejected (cancelled/postponed) to reserve or redistribute the limited capabilities and resources (such as hospital beds and patient care specialists) toward COVID-19 patient care. These lockdowns restricted patients from entering clinics, hospitals, or OPDs. This temporary restriction of non-emergent healthcare services is anticipated to limit the market growth. However, demand for amniotic products is anticipated to grow over the coming years.

Type Outlook

By type, the market is classified into cryopreserved amniotic membrane and dehydrated amniotic membrane. In 2022, the cryopreserved amniotic membrane segment held the highest revenue share in the market. The cryopreserved membrane is typically retained at -80 °C in a cell culture medium containing 50% glycerol. The amniotic membrane's histological and biological characteristics are well-preserved in cryopreserved amniotic membranes. Consequently, cryopreserved membranes are primarily used in eye operations to reduce inflammation and improve recovery. As a result, this market is predicted to expand at a profitable pace over the forecast period.

End-user Outlook

Based on end user, the market is categorized into hospitals & ambulatory surgical centers and other end users. In 2022, the hospitals segment dominated the market with maximum revenue share. The increasing use of amniotic membranes in ASCs is another element that should accelerate market expansion. Using these items is simple and efficient, and it also helps the wound heal without frequent trips to clinics or hospitals. As hospitals are the primary care environments that facilitate simple treatment for a wide range of diseases, this is primarily owing to frequent visits by patients. This encourages the segment’s expansion.



Application Outlook

On the basis of application, the market is bifurcated into wound care, orthopedics, ophthalmology, and other applications. In 2022, the ophthalmology segment covered a considerable revenue share in the market. It is due to various product developments and discoveries from regenerative medicine research that would enable improved utilization of amniotic membranes in the abovementioned segment. Further, the segment’s growth is driven by the rising incidence of ophthalmologic conditions globally.

Regional Outlook

Region wise, the market analyzed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The high incidence of chronic wounds and diabetes, the rising cost of healthcare, the rise in the number of surgical operations performed in the US are propelling the regional market’s growth. Further, the rising geriatric population, and the significant presence of amniotic product manufacturers all contribute to the market's expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiMedx Group, Inc., Integra LifeSciences Holdings Corporation, Organogenesis Holdings, Inc., Amnio technology LLC, Alliqua Biomedical, Inc., Human Regenerative Technologies, LLC (Skye Biologics Holdings Company), Corza Ophthalmology (Corza Medical, Inc.), BioTissue Holdings, Inc., Applied Biologics LLC

Scope of the Study

By Type

  • Cryopreserved Amniotic Membranes
  • Dehydrated Amniotic Membranes

By Application

  • Wound Care
  • Ophthalmology
  • Orthopedics
  • Others

By End-user

  • Hospital & Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • MiMedx Group, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Holdings, Inc.
  • Amnio technology LLC
  • Alliqua Biomedical, Inc.
  • Human Regenerative Technologies, LLC (Skye Biologics Holdings Company)
  • Corza Ophthalmology (Corza Medical, Inc.)
  • BioTissue Holdings, Inc.
  • Applied Biologics LLC

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Amniotic Products Market, by Type
1.4.2 Global Amniotic Products Market, by Application
1.4.3 Global Amniotic Products Market, by End User
1.4.4 Global Amniotic Products Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Global Amniotic Products Market by Type
4.1 Global Cryopreserved Amniotic Membranes Market by Region
4.2 Global Dehydrated Amniotic Membranes Market by Region
Chapter 5. Global Amniotic Products Market by Application
5.1 Global Wound Care Market by Region
5.2 Global Ophthalmology Market by Region
5.3 Global Orthopedics Market by Region
5.4 Global Others Market by Region
Chapter 6. Global Amniotic Products Market by End User
6.1 Global Hospital & Ambulatory Surgical Centers Market by Region
6.2 Global Others Market by Region
Chapter 7. Global Amniotic Products Market by Region
7.1 North America Amniotic Products Market
7.1.1 North America Amniotic Products Market by Type
7.1.1.1 North America Cryopreserved Amniotic Membranes Market by Country
7.1.1.2 North America Dehydrated Amniotic Membranes Market by Country
7.1.2 North America Amniotic Products Market by Application
7.1.2.1 North America Wound Care Market by Country
7.1.2.2 North America Ophthalmology Market by Country
7.1.2.3 North America Orthopedics Market by Country
7.1.2.4 North America Others Market by Country
7.1.3 North America Amniotic Products Market by End User
7.1.3.1 North America Hospital & Ambulatory Surgical Centers Market by Country
7.1.3.2 North America Others Market by Country
7.1.4 North America Amniotic Products Market by Country
7.1.4.1 US Amniotic Products Market
7.1.4.1.1 US Amniotic Products Market by Type
7.1.4.1.2 US Amniotic Products Market by Application
7.1.4.1.3 US Amniotic Products Market by End User
7.1.4.2 Canada Amniotic Products Market
7.1.4.2.1 Canada Amniotic Products Market by Type
7.1.4.2.2 Canada Amniotic Products Market by Application
7.1.4.2.3 Canada Amniotic Products Market by End User
7.1.4.3 Mexico Amniotic Products Market
7.1.4.3.1 Mexico Amniotic Products Market by Type
7.1.4.3.2 Mexico Amniotic Products Market by Application
7.1.4.3.3 Mexico Amniotic Products Market by End User
7.1.4.4 Rest of North America Amniotic Products Market
7.1.4.4.1 Rest of North America Amniotic Products Market by Type
7.1.4.4.2 Rest of North America Amniotic Products Market by Application
7.1.4.4.3 Rest of North America Amniotic Products Market by End User
7.2 Europe Amniotic Products Market
7.2.1 Europe Amniotic Products Market by Type
7.2.1.1 Europe Cryopreserved Amniotic Membranes Market by Country
7.2.1.2 Europe Dehydrated Amniotic Membranes Market by Country
7.2.2 Europe Amniotic Products Market by Application
7.2.2.1 Europe Wound Care Market by Country
7.2.2.2 Europe Ophthalmology Market by Country
7.2.2.3 Europe Orthopedics Market by Country
7.2.2.4 Europe Others Market by Country
7.2.3 Europe Amniotic Products Market by End User
7.2.3.1 Europe Hospital & Ambulatory Surgical Centers Market by Country
7.2.3.2 Europe Others Market by Country
7.2.4 Europe Amniotic Products Market by Country
7.2.4.1 Germany Amniotic Products Market
7.2.4.1.1 Germany Amniotic Products Market by Type
7.2.4.1.2 Germany Amniotic Products Market by Application
7.2.4.1.3 Germany Amniotic Products Market by End User
7.2.4.2 UK Amniotic Products Market
7.2.4.2.1 UK Amniotic Products Market by Type
7.2.4.2.2 UK Amniotic Products Market by Application
7.2.4.2.3 UK Amniotic Products Market by End User
7.2.4.3 France Amniotic Products Market
7.2.4.3.1 France Amniotic Products Market by Type
7.2.4.3.2 France Amniotic Products Market by Application
7.2.4.3.3 France Amniotic Products Market by End User
7.2.4.4 Russia Amniotic Products Market
7.2.4.4.1 Russia Amniotic Products Market by Type
7.2.4.4.2 Russia Amniotic Products Market by Application
7.2.4.4.3 Russia Amniotic Products Market by End User
7.2.4.5 Spain Amniotic Products Market
7.2.4.5.1 Spain Amniotic Products Market by Type
7.2.4.5.2 Spain Amniotic Products Market by Application
7.2.4.5.3 Spain Amniotic Products Market by End User
7.2.4.6 Italy Amniotic Products Market
7.2.4.6.1 Italy Amniotic Products Market by Type
7.2.4.6.2 Italy Amniotic Products Market by Application
7.2.4.6.3 Italy Amniotic Products Market by End User
7.2.4.7 Rest of Europe Amniotic Products Market
7.2.4.7.1 Rest of Europe Amniotic Products Market by Type
7.2.4.7.2 Rest of Europe Amniotic Products Market by Application
7.2.4.7.3 Rest of Europe Amniotic Products Market by End User
7.3 Asia Pacific Amniotic Products Market
7.3.1 Asia Pacific Amniotic Products Market by Type
7.3.1.1 Asia Pacific Cryopreserved Amniotic Membranes Market by Country
7.3.1.2 Asia Pacific Dehydrated Amniotic Membranes Market by Country
7.3.2 Asia Pacific Amniotic Products Market by Application
7.3.2.1 Asia Pacific Wound Care Market by Country
7.3.2.2 Asia Pacific Ophthalmology Market by Country
7.3.2.3 Asia Pacific Orthopedics Market by Country
7.3.2.4 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Amniotic Products Market by End User
7.3.3.1 Asia Pacific Hospital & Ambulatory Surgical Centers Market by Country
7.3.3.2 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Amniotic Products Market by Country
7.3.4.1 China Amniotic Products Market
7.3.4.1.1 China Amniotic Products Market by Type
7.3.4.1.2 China Amniotic Products Market by Application
7.3.4.1.3 China Amniotic Products Market by End User
7.3.4.2 Japan Amniotic Products Market
7.3.4.2.1 Japan Amniotic Products Market by Type
7.3.4.2.2 Japan Amniotic Products Market by Application
7.3.4.2.3 Japan Amniotic Products Market by End User
7.3.4.3 India Amniotic Products Market
7.3.4.3.1 India Amniotic Products Market by Type
7.3.4.3.2 India Amniotic Products Market by Application
7.3.4.3.3 India Amniotic Products Market by End User
7.3.4.4 South Korea Amniotic Products Market
7.3.4.4.1 South Korea Amniotic Products Market by Type
7.3.4.4.2 South Korea Amniotic Products Market by Application
7.3.4.4.3 South Korea Amniotic Products Market by End User
7.3.4.5 Singapore Amniotic Products Market
7.3.4.5.1 Singapore Amniotic Products Market by Type
7.3.4.5.2 Singapore Amniotic Products Market by Application
7.3.4.5.3 Singapore Amniotic Products Market by End User
7.3.4.6 Malaysia Amniotic Products Market
7.3.4.6.1 Malaysia Amniotic Products Market by Type
7.3.4.6.2 Malaysia Amniotic Products Market by Application
7.3.4.6.3 Malaysia Amniotic Products Market by End User
7.3.4.7 Rest of Asia Pacific Amniotic Products Market
7.3.4.7.1 Rest of Asia Pacific Amniotic Products Market by Type
7.3.4.7.2 Rest of Asia Pacific Amniotic Products Market by Application
7.3.4.7.3 Rest of Asia Pacific Amniotic Products Market by End User
7.4 LAMEA Amniotic Products Market
7.4.1 LAMEA Amniotic Products Market by Type
7.4.1.1 LAMEA Cryopreserved Amniotic Membranes Market by Country
7.4.1.2 LAMEA Dehydrated Amniotic Membranes Market by Country
7.4.2 LAMEA Amniotic Products Market by Application
7.4.2.1 LAMEA Wound Care Market by Country
7.4.2.2 LAMEA Ophthalmology Market by Country
7.4.2.3 LAMEA Orthopedics Market by Country
7.4.2.4 LAMEA Others Market by Country
7.4.3 LAMEA Amniotic Products Market by End User
7.4.3.1 LAMEA Hospital & Ambulatory Surgical Centers Market by Country
7.4.3.2 LAMEA Others Market by Country
7.4.4 LAMEA Amniotic Products Market by Country
7.4.4.1 Brazil Amniotic Products Market
7.4.4.1.1 Brazil Amniotic Products Market by Type
7.4.4.1.2 Brazil Amniotic Products Market by Application
7.4.4.1.3 Brazil Amniotic Products Market by End User
7.4.4.2 Argentina Amniotic Products Market
7.4.4.2.1 Argentina Amniotic Products Market by Type
7.4.4.2.2 Argentina Amniotic Products Market by Application
7.4.4.2.3 Argentina Amniotic Products Market by End User
7.4.4.3 UAE Amniotic Products Market
7.4.4.3.1 UAE Amniotic Products Market by Type
7.4.4.3.2 UAE Amniotic Products Market by Application
7.4.4.3.3 UAE Amniotic Products Market by End User
7.4.4.4 Saudi Arabia Amniotic Products Market
7.4.4.4.1 Saudi Arabia Amniotic Products Market by Type
7.4.4.4.2 Saudi Arabia Amniotic Products Market by Application
7.4.4.4.3 Saudi Arabia Amniotic Products Market by End User
7.4.4.5 South Africa Amniotic Products Market
7.4.4.5.1 South Africa Amniotic Products Market by Type
7.4.4.5.2 South Africa Amniotic Products Market by Application
7.4.4.5.3 South Africa Amniotic Products Market by End User
7.4.4.6 Nigeria Amniotic Products Market
7.4.4.6.1 Nigeria Amniotic Products Market by Type
7.4.4.6.2 Nigeria Amniotic Products Market by Application
7.4.4.6.3 Nigeria Amniotic Products Market by End User
7.4.4.7 Rest of LAMEA Amniotic Products Market
7.4.4.7.1 Rest of LAMEA Amniotic Products Market by Type
7.4.4.7.2 Rest of LAMEA Amniotic Products Market by Application
7.4.4.7.3 Rest of LAMEA Amniotic Products Market by End User
Chapter 8. Company Profiles
8.1 MiMedx Group. Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Integra LifeSciences Holdings Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Organogenesis Holdings, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Amnio Technology, LLC
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Product Launches and Product Expansions:
8.4.3 SWOT Analysis
8.5 Alliqua BioMedical, Inc.
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Human Regenerative Technologies, LLC (Skye Biologics Holdings Company)
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Corza Ophthalmology (Corza Medical, Inc.)
8.7.1 Company Overview
8.7.2 SWOT Analysis
8.8 BioTissue Holdings, Inc.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Applied Biologics LLC
8.9.1 Company Overview
8.9.2 SWOT Analysis
Chapter 9. Winning Imperative Amniotic Products Market

Companies Mentioned

  • MiMedx Group, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Holdings, Inc.
  • Amnio technology LLC
  • Alliqua Biomedical, Inc.
  • Human Regenerative Technologies, LLC (Skye Biologics Holdings Company)
  • Corza Ophthalmology (Corza Medical, Inc.)
  • BioTissue Holdings, Inc.
  • Applied Biologics LLC

Methodology

Loading
LOADING...